Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse

Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. of the rate of decline of residual renal function in incident dialysis patients. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. An evaluation of an integrative care approach for end-stage renal disease patients. aminoglycosides for peritonitis do not affect residual renal function. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. Acute effects of high-dose furosemide on residual renal function in CAPD patients. A, Bargman J. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Do not be misguided by guidelines: the calcium  phosphate product can be a Trojan horse